Table 3.
Variables | d-ROMs | P* | OR (CI 95%) | |
---|---|---|---|---|
Controls | ||||
Gender | Female | Male | ||
319.7 ± 66.6 | 275.0 ± 43.1 | .009 | 6.5 (1.7–24.3) | |
Smoking | Yes | No | ||
325.9 ± 68.8 | 272.0 ± 36.6 | .001 | 6.3 (1.7–23.7) | |
HIV-1 infection | ||||
HAART | Yes | No | ||
366.1 ± 68.6 | 322.4 ± 41.5 | .001 | 3.4 (1.3–8.7) | |
HIV-1 treated | ||||
Gender | Female | Male | ||
393.0 ± 78.4 | 343.8 ± 50.5 | .000 | 3.7 (0.9–14.2) | |
Smoking | Yes | No | ||
362.1 ± 60.4 | 366.1 ± 56.4 | .8 | 0.7 (0.2–2.6) | |
CD4 T-cells | ≥ 350 cells/mL | < 350 cells/mL | .6 | 0.9 (0.2–3.5) |
364.0 ± 69.1 | 373.1 ± 69.0 | |||
HIV-RNA | ≤ 400 cp/mL | >400 cp/mL | .7 | 1.1 (0.3–4.6) |
364.6 ± 70.1 | 372.3 ± 64.8 | |||
Drug class | PI | NNRTI | ||
372.5 ± 75.1 | 359.7 ± 61.6 | .4 | 1.3 (0.4–4.4) | |
Nelfinavir | Yes | No | ||
398.2 ± 95.6 | 359.9 ± 61.2 | .056 | ∞ | |
Nevirapine | Yes | No | ||
372.3 ± 63.4 | 364.4 ± 70.6 | .7 | 1.8 (0.4–9.1) | |
Efavirenz | Yes | No | ||
348.1 ± 54.2 | 370.6 ± 71.6 | .2 | 0.4 (0.1–1.5) | |
HAART adherence | Optimal | Poor | ||
378.5 ± 71.7 | 336.0 ± 50.7 | .008 | 4.2 (1.1–15.5) | |
Other drugs + HAART | Yes | No | ||
371.8 ± 61.7 | 363.1 ± 72.7 | .6 | 2.2 (0.6–8.6) | |
Psychiatric drugs + HAART | Yes | No | ||
399.4 ± 51.5 | 359.7 ± 70.1 | .047 | ∞ | |
HIV-HCV co-infected | Yes | No | ||
359.7 ± 57.9 | 371.3 ± 79.1 | .5 | 1.1 80.3–3.3 | |
ALT | ≤ 41 UI/L | < 40 UI/L | .2 | 1.0 (0.33–3.3) |
374.2 ± 80.8 | 355.0 ± 46.3 | |||
Glycemia | ≤ 100 mg/dL | < 100 mg/dL | .1 | 2.3 (0.7–8.1) |
372.3 ± 71.1 | 342.9 ± 54.9 | |||
Cholesterolemia | ≤ 180 mg/dL | > 180 mg/dL | .2 | 0.7 (0.2–2.4) |
355.0 ± 61.6 | 372.7 ± 72.5 | |||
Triglyceridemia | ≤ 170 mg/dL | > 170 mg/dL | .4 | 0.8 (0.2–2.8) |
371.2 ± 79.4 | 358.4 ± 48.5 | |||
HIV-1 untreated | ||||
Gender | Female | Male | ||
336.3 ± 49.1 | 309.6 ± 28.9 | .076 | 0.8 (0.2–3.5) | |
Smoking | Yes | No | ||
312.1 ± 30.0 | 331.4 ± 48.7 | .2 | 0.8 (0.2–3.5) | |
HIV-HCV co-infected | Yes | No | ||
330.4 ± 38.9 | 314.7 ± 43.0 | .3 | 2.5 (0.5–11.4) | |
ALT | ≤ 41 UI/L | < 40 UI/L | .3 | 0.2 (0.04–1.4) |
316.9 ± 40.2 | 332.4 ± 43.3 |
Data are expressed as mean ± SD.
*Calculated by One-Way ANOVA.